In the present communication, we utilize the assay to examine the T-lymphocyte proliferative responses to seven different antigens; the antibody responses to these antigens have previously been shown to be under the control of Ir genes. We demonstrate here that a close parallel exists between the genetic control of T-lymphocyte proliferation and that of antibody formation, suggesting that the same MHC gene controls both types of immune responsiveness. These observations make it appear highly unlikely that Ir genes are expressed solely in B lymphocytes, because one would expect that mice with a defect limited to B lymphocytes would show a normal T-lymphocyte proliferative response.
Immunizations. Mice were immunized with 1-20 ~g of antigen emulsified in complete Freund's adjuvant containing 1 mg/ml Mycobacterium tuberculosis, strain H37Ra (Difco Laboratories). Each mouse received 0.1 ml of emulsion distributed equally between the two hind foot pads.
Preparation of PETLES. 2.5 wk after immunization, mice were injected intraperitoneally with 1 ml of 10% Brewer's thioglycollate (Difco Laboratories). 5 days later the peritoneal exudate cells (PEC) were harvested as described in detail elsewhere (4) . Purification of the lymphoid population previously involved adherence to glass followed by passage of the nonadherent cells over nylon wool columns. In the present studies this procedure was greatly simplified by eliminating the glass adherence step and increasing the size of the nylon wool columns. 3.5 g of washed nylon wool were packed into a 35 ml syringe and used to fractionate 4-6 × l0 s PEC; 2.5-g columns in a 20 ml syringe were used for 2-3 × l0 s PEC. The cells were incubated on the column for 1 h, with two 3-to 4-ml washes into the column at 15-and 30-min intervals. The nonadherent cells were eluted with 100 ml of EHAA culture medium (10) containing 10% heat-inactivated (56°C, 45 min) fetal calf serum (FCS). This population contained approximately twice as many macrophages as the peritoneal exudate T-lymphocyte-enriched cells (PETLES) described previously (4) , but otherwise was very similar in composition. The mean composition using the new procedure was 13% macrophages, 55% lymphocytes, 2% B lymphocytes (identified by staining with fluoresceinconjugated rabbit antimouse immunoglobulin), and 32% eosinophils for 107 experiments. The mean composition, using the old procedure was 7% macrophages, 54% lymphocytes, 2% B lymphocytes, and 39% eosinophils. The slight enrichment of macrophages in the new PETLES did not affect their responsiveness to antigen. Proliferation ensued over as wide a dose range of antigen as before and the response was almost completely eliminated by pretreatment of the population with anti-Thy 1 antiserum plus C.
Cell Cultures. 1 × 10 ' PETLES were cultured in sterile, U bottom, polystyrene, microculture plates (Cooke Laboratory Products Div., Dynatech Laboratories Inc., Alexandria, Va.) containing 0.2 ml of EHAA medium supplemented with 10% FCS and 10-50 gg/ml of gentamycin instead of streptomycin. Antigens were diluted to twice optimal concentrations (100 gg/ml for all antigens except PPD, which was 20 ~g/ml, and Nase which was 1 ~g/ml) with supplemented EHAA medium; 0.1 ml of diluted antigen was then mixed with 0.1 ml of cells.
Cells were cultured for 5 days at 37°C in a humidified atmosphere of 2% CO2 and 98% air. Approximately 16-18 h before harvesting the cultures were pulsed with 1 ~Ci of tritiated-methylthymidine (sp act 5 Ci/mmol; Amersham/Searle Corp., Arlington Heights, Ill.) in 10 ~l of PBS. The cultures were harvested onto glass fiber filter paper strips with a MASH II automated harvestor (Microbiological Associates, Rockville, Md.) and washed with distilled water and 95% ethanol. The filter discs for each sample were placed in 2 ml of Hydromix scintillation fluid (Yorktown Research Inc., Hackensack, N. J.) and the radioactivity monitored in a Beckman liquid scintillation counter (Beckman Instruments, Inc., Fullerton, Calif.). All determinations were done in triplicate and the data are expressed as counts per minute _+ standard error of the mean (SEM).
Identification of Dividing Cells in Antigen-Stimulated PETLES. 2 × 10 ~ PETLES per well
were cultured in EHAA medium plus 10% FCS for 4 or 5 days in the presence of PPD or LPS. The cells were harvested by suspending with a Pasteur pipette. The pool of cells from 10 to 20 wells was separated on a Ficoll-Hypaque density gradient (p = 1.077) for 35 min at room temperature (11) to remove dead cells and debris. The interface population was recovered, washed twice with Eagle's minimal essential medium, and the cells counted. Recovery of live cells ranged from 10 to 33% of the initial number of PETLES plated. The cells were then washed twice at 4°C with a 0.15 M NaC1, 0.05 M phosphate buffer, pH 7.2, containing 2% bovine serum albumin and 0.2% NaN.~ (BSA-azide buffer) (12) and divided into two groups. One was treated with anti-Thy 1.2 serum [raised in AKR mice by injection of C3H thymocytes as described by Reif and Allen (13) ], the other with normal mouse serum. In each case 50 ~l of neat serum was used/10 ~ cells. The cells were incubated on ice for 30 min. They were then washed three times with the BSA-azide buffer and reacted for 30 min at 4°C with fluorescein-conjugated rabbit antimouse IgG (F1-RaMIG) (both antiheavy and light chain specificities) (lot no. 6117; Cappell Laboratories, Inc., Dowingtown, Pa.). After another three washes wet mounts were prepared and read. Blast cells were identified mainly on the basis of their large size and the absence of numerous phagocytic vesicles (to distinguish them from macrophages). These cells were then scored as positive or negative for fluorescence using a Leitz orthoplan incident-illumination microscope (E. Leitz, Inc., Rockleigh, N. J.), the details of which have been described previously (12) . In the population stained with normal mouse serum and then F1-RaMIG, positive cells were classified as B lymphocytes. In the population stained with antiThy 1.2 followed by F1-RaMIG, positive cells constituted both T and B lymphocytes. The percentage of T-cell blasts was obtained by subtraction of the first from the second determinations.
Results

Demonstration that Proliferating Cells are Principally T Lymphocytes.
We have previously demonstrated that antigen-induced proliferation of PETLES is sensitive to pretreatment with anti-Thy 1 antiserum and C, and that the response exhibits carrier specificity (4) . In addition, since B lymphocytes, as defined by staining with F1-RaMIG, are relatively rare in PETLES (2.1 _+ 0.3%, n = 32), it seemed reasonable to conclude that the proliferative response measured principally the participation of T lymphocytes. However, because this assertion is particularly important for the use of the assay in the study of Irgene-controlled systems, it seemed necessary to directly rule out any significant contribution of T-cell-dependent, B-lymphocyte proliferation to the total magnitude of the proliferative response. The question was addressed by examining the surface markers of the cells dividing in response to antigen. Blast cells obtained 4 or 5 days after the stimulation of PETLES with PPD were examined for either immunoglobulin or Thy 1 on their surfaces (see Materials and Methods). In four experiments using immunofluorescence to identify surface markers and morphological criteria to identify blasts, a mean of 5% of the blast cells was found to bear immunoglobulin, a mean of 85% bore Thy 1.2, and 10% bore neither marker. In contrast, when PETLES were stimulated with the B-cell mitogen, LPS, 80% of the small number of recovered blasts bore immunoglobulin, demonstrating that if immunoglobulin-bearing cells made a measurable contribution to the antigen-induced proliferative response, they should have been detected. We conclude from this study that 85% or more of the PETLES which proliferate in response to antigen are members of the T-lymphocyte line. Representative results for each of the seven antigens, using 1 x 10 :~ PETLES and the maximum stimulating antigen concentration (usually 100 ~g/ml), are shown in Tables I-III. Antigens in all three classes proved satisfactory for use in the proliferation assay, evoking significant tritiated thymidine incorporation into PETLES from responder strains, although generally less than the incorporation seen by the same cells in response to PPD. Strains designated as nonresponders to these antigens showed no statistically significant difference (Student's t test) in the counts per minute incorporated in the presence of antigen, compared to the counts per minute incorporated in the presence of medium alone. In all cases, nonresponder strains showed excellent responses to PPD. Furthermore, strains which were nonresponders to any one of the seven antigens were always responders to several of the other antigens.
Genetic Control of
It was usually possible to unambiguously designate strains tested as responders or nonresponders; however, in the case of the protein antigens LDHB and Nase, some strains mounted a weak but significant response at higher immunizing doses. LDHs elicited no response from B10.A/SgSn mice when these animals were immunized with a low dose of the antigen (1 ~g) but it did elicit a weak response when the mice were immunized with a higher dose of antigen (10 ~tg (10) 2,800 ± 800 22,800 ± 2,400 71,900 ± 1,500 ++ C3H/HeN (10) 580 ± 130 18,000 ± 1,200 42,400 ± 900 ++ SJL/J (10) 4,100 ± 1,700 3,200 ± 500 69,200 ± 9,000 -DBA/1J (10) 3,600 ± 500 3,800 ± 300 44,300 ± 2,300 -GLT BALB/cAnN (10) 2,400 ± 100 18,900 ± 2,300 124,700 + 11,100 ++ B10.D2/nSn (10) 450 ± 60 32,500 ± 4,500 59,600 ± 4,600 + + SJL/J (10) 5,200 ± 1,300 3,600 ± 700 48,100 ± 2,400 C57BL/10Sn (10) 1,600 ± 500 2,200 ± 600 23,300 ± 2,600 Nase SJL/J (10) 2,200 ± 300 134,900 ± 8,300 179,000 ± 5,000 + + SJL/J (1) 3,900 ± 1,300 90,900 ± 11,600 170,000 ± 4,100 ++ BALB/c AnN (10) 2,200 ± 400 61,000 ± 5,200 112,000 ± 1,600 ++ DBA/1J (10) 2,300 _+ 1,100 2,200 ± 500 29,100 ± 50 -C57BL/10Sn (10) 1,100 ± 400 6,000 ± 500 46,900 ± 2,500 + C57BL/10Sn (1) 1,400 ± 400 1,300 ± 200 40,500 ± 800 LDH~ C57BL/10Sn (10) 2,600 ± 800 18,000 ± 2,000 43,500 ± 3,500 ++ C57BL/10Sn (1) 9,400 ± 800 50,500 ± 2,600 79,500 ± 4,900 ++ SJL/J (10) 3,700 ± 1,300 28,500 ± 3,900 67,800 ± 7,000 ++ AKR/J (10) 1,000 ± 200 3,800 ± 1,I00 36,400 ± 900 + B10.A/SgSn (10) 1,900 _+ 800 4,700 ± 1,300 92,000 ± 4,700 + B10.A/SgSn (1) 2,300 ± 700 2,900 ± 900 163,500 ± 6,500 - (20) 1,800 ± 200 28,500 ± 1,700 53,000 ± 9,300 + + B10.BR/SgSn (20) 1,300 ± 300 51,900 ± 400 78,600 ± 4,400 ++ B10.A/SgSn (10) 370 ± 10 16,800 ± 1,000 45,700 ± 4,600 ++ B10.M/Sn (20) 1,000 ± 100 1,100 ± 200 18,000 _+ 1,200 -SJL/J (10) 3,200 ± 250 4,900 ± 1,900 49,300 ± 9,600 * Mice were immunized with 1-20 ttg of antigen in CFA 3-5 wk before collection and preparation of PETLES. 1 × 105 cells were cultured with 1, 10, or 100 t~g/ml of the immunizing antigen, with 20-40 tLg/ml of PPD, or with medium alone. Stimulation was assessed 5 days later by measuring the incorporation of an 18 h pulse of tritiated thymidine. The data are expressed as the mean counts per minute ± the standard error of the mean for triplicate determinations. For the antigen-stimulated cultures only the data from the concentration giving the largest stimulation are shown. This was generally 100 tLg/ml for GAT, GLT, LDHH, and (¢P,G)-A--L, and 1 tLg/ml for Nase. $ The numbers in parentheses after each strain indicate the immunizing dose of the antigen in micrograms.
§ Strains were assigned a nonresponder status (-) if the incorporation of thymidine in the presence of the immunizing antigen was not significantly different by a Student's t test from the incorporation of thymidine in the medium controls. Responder strains were divided into weak ( + ) and strong ( + + ) categories depending on the magnitude of the statistically significant response. Strong responders gave E/C-1 of 4 or more while weak responders gave E/C-1 of <4.
cases it seems more appropriate to refer to the strains as "low responders." In each instance, with one exception to be discussed subsequently, the designation of responder or nonresponder assigned to a strain based on the capacity of its T lymphocytes to proliferate in vitro was the same as the designation previously given the strain on the basis of its in vivo antibody response (1, 2) . This is shown most clearly in Tables II and III, indeed coded for by genes in the MHC was shown in the experiments with congenic resistant lines. For (T,G)-A--L, the B10 strain was a responder, whereas the congenic lines B10.A and B10.BR, which possess a and k MHC haplotypes, respectively, on a B10, non-MHC background, were nonresponders. Thus, the B10 MHC genes are essential for responsiveness to (T,G)-A--L. Conversely, when the MHC genes of B10 were associated with the non-MHC genes of nonresponder A mice, as is found in the congenic strain, A. BY, the mice were responders. Thus, MHC genes are sufficient in themselves to confer responsiveness to the animal. A similar analysis can be made for the response to TEPC 15. Responsiveness appeared to be a dominant genetic trait as shown by the ability of (B10 × B10.A)F~ mice to respond to both (T,G)-A--L and TEPC 15. By applying similar reasoning to the responses of these mice to TEPC-15, one can locate one locus controlling responsiveness to this antigen as also being to the left of I-B. In this case, however, responsiveness is determined by the a haplotype and nonresponsiveness by the b haplotype. These results are precisely the same as those which were obtained by examining the antibody responses of these strains to both (T,G)-A--L and TEPC-15 (14, 15) .
Mapping of the Ir Genes Controlling the T-Lymphocyte Proliferative Responses to (T,G)-A--L and TEPC-15 to the K or I-A Region of the MHC. A
Antibody responses to TEPC-15, which is a BALB/c IgA myeloma protein, are actually determined by two genetic loci, the MHC-linked Ir genes, in which possession of a responder allele allows a response to occur, and the IgCH region, in which sharing of the BALB/c IgA allotype prevents a response (16) . Table III shows that the same is true for T-lymphocyte proliferation. AKR and B10.BR mice possess the H-2 k haplotype as well as an allotypic form of IgA different from that of the BALB/c. These strains both show substantial proliferative responses to TEPC-15. On the other hand, C3H mice, although bearing the same responder allele in the MHC as AKR and B10.BR, nevertheless fail to respond to TEPC-15 because they possess IgA molecules of the same allotype as BALB/c.
One other point should be noted about the data in Table III . The SJL/J strain failed to respond to TEPC-15 (despite multiple attempts, including boosting), yet recombinant strains carrying the H-2" genes in the K and I-A regions, such as B10.HTT, B10.S(7R), and B10.S(9R), were responders, although rather weak ones. The results obtained with recombinant strains parallel the findings for the antibody responsiveness of H-2" haplotype strains to TEPC-15, whereas the result with the SJL strain does not. The reason for this single exception is unknown.
The major conclusion to be drawn from these experiments is that the genetic control of the T-lymphocyte proliferative response in mice closely parallels the genetic capacity of these animals to generate an antibody response. This correlation suggests that the same immune response gene controls both types of responses. Because the proliferative assay is almost completely devoid of any contribution from B cells, it seems quite unlikely that any of the Ir genes controlling responses to the seven antigens studied can be expressed solely in B lymphocytes.
Discussion
In this paper we have used the antigen-induced proliferative response of mouse PETLES to assay T-lymphocyte function in Ir-gene-controlled systems. Although studies of this type have been reported previously, notably for DNA synthetic responses of guinea pig T lymphocytes (17) , the superior understanding of MHC genetics in the mouse makes an asesssment ofT-cell function in this species particularly important. Furthermore, recent studies of collaboration between B cells and helper T cells (or T-cell factors), in immune responses controlled by specific Ir genes, have suggested that the locus of expression of at least some Ir-gene products is in the B lymphocyte rather than in the T lymphocyte (18, 19) . The proliferative response of PETLES allows a direct examination of T-lymphocyte function in mice with such proposed B-lymphocyte defects.
As a prelude to the analysis of the proliferative response of PETLES in Irgene-controlled systems, it was mandatory to establish that this assay, indeed, measured only T-lymphocyte function. We have previously shown that very few B cells are present in PETLES (2%), that the response of PETLES to antigen can be essentially eliminated by pretreatment with anti-Thy 1.2 and C, and that the responding cells exhibit carrier specificity. In this paper we further show that at least 85% of the blast cells which appear after antigen stimulation bear the Thy 1.2 marker and that only 5% bear detectable surface immunoglobulin. Thus, from this extensive series of criteria it seems quite clear that the proliferative response of PETLES to antigen can be regarded as predominantly reflecting Tlymphocyte function.
We then studied the responsiveness of PETLES from mice immunized to seven individual antigens, the antibody responses to which are known to be under the control of specific Ir genes. In each case, PETLES from animals previously designated as responders by serum antibody responses (1, 2) displayed substantial incorporation of tritiated thymidine when stimulated in vitro. Similarly, PETLES from animals previously classified as low or nonresponders on the basis of serum antibody titers showed either no or only modest net incorporation of tritiated thymidine when confronted with antigen in vitro. This concordance in assignment of responder status by examining antibody production and T-cell proliferative responses suggests that the same Ir genes (or very closely linked genes) control both types of immune responses. Furthermore, if an Ir-gene product were expressed exclusively in B lymphocytes, PETLES from such "nonresponders" should mount a normal T-lymphocyte proliferative response. Since this was not the case, we conclude that none of the Ir genes studied in these experiments are expressed exclusively in B lymphocytes.
This point seems especially germane for the immune response to (T,G)-A--L. In our hands, all mice classified as nonresponders by antibody assay proved to also be nonresponders in the proliferation assay. In particular, mice of the H-2 k haplotype, including B10.BR/SgSn, AKR/J, and C3H/HeN were all nonresponders. Similarly, Lonai and McDevitt (20) Although these results are in apparent contrast to each other, several ways to make them consistent can be proposed. It is possible that the nonresponder allele for the (T,G)-A--L Ir gene, which mice of the H-2 k haplotype have, is expressed in both B lymphocytes and T lymphocytes, but that some T-lymphocyte functions, such as the production of collaborative factors, are not controlled by this Ir-gene product, while others, such as T-lymphocyte proliferation, are critically dependent on the expression of a responder allele. As a variant on this approach, it might be postulated that the (T,G)-A--L nonresponder allele in the H-2 ~ haplotype is expressed in B lymphocytes and in certain subclasses of T lymphocytes (22) . The cells important in factor production and perhaps in helper function might be a set of T lymphocytes whose activation does not require the expression of the responder allele. Proliferation, on the other hand, might be the initial response of a set of T lymphocytes which required the function of this Irgene product. Alternatively, the proliferative response might require the action of a T cell analogous to the factor producing cell, in order to activate the cell capable of proliferation. In this case, an analogy between the proliferating T cell and the B cell could be drawn in that both would be "helped" by the factorproducing cell.
Another possibility is that the (T,G)-A--L nonresponder allele in H-2 k mice is expressed in macrophages, as well as B lymphocytes, but not at all in T lymphocytes. The antigen-induced proliferation of guinea pig T lymphocytes has been shown to be dependent upon the presence of macrophages (23) . Furthermore, in the activation of T lymphocytes from (responder × nonresponder)F~ guinea pigs, macrophages from the responder parent are much more effective at presenting antigen than macrophages from the nonresponder parent (24) . If similar macrophage dependence can be shown for the proliferation of mouse PETLES, then having macrophages express Ir-gene functions would seem to be a most attractive possibility. However, in order to explain the differing results of the factor production and the proliferation assays, it would also be necessary to postulate that both priming and in vitro activation of factor-producing T lymphocytes are not macrophage dependent.
In this discussion of the (T,G)-A--L system, we have not considered mice which possess a nonresponder allele at the Ir locus that functions in factor producing T lymphocytes, as defined by Taussig et al. (21) . Mice, such as B10.M (H-2r) , fail to produce-T-cell factor but display normal B-cell acceptor function (21) . Studies on the proliferative responses of H-2 f mice and of F~ hybrids between the two types of nonresponders, such as (H-2 k × H-20, are now in progress.
Summary
The recent introduction of a reliable, T-lymphocyte proliferation assay, which utilizes thioglycollate-induced, nylon wool column-passed, peritoneal exudate lymphocytes from immune mice (PETLES), allowed us to investigate the genetic control of murine immune responses at the T-lymphocyte level. Examination of the blast cells generated in this population 5 days after stimulation with antigen, revealed that 85% of the cells bore the Thy 1 antigen on their surface, whereas only 5% bore immunoglobulin. Thus, the assay can be considered to measure almost exclusively T-lymphocyte function. This assay was used to examine the T-lymphocyte proliferative responses to seven different antigens: poly(Glu~°Ala3°Tyrl"), poly(Glu'~Lys38Tyr4), poly-(Tyr,Glu)-poly-D,L-Ala--polyLys, poly-(Phe,Glu)-poly-D,L-Ala--poly-Lys, staphylococcal nuclease, lactate dehydrogenase H4, and the BALB/c IgA myeloma protein, TEPC-15. PETLES from a large number of different inbred mouse strains, including H-2 congenic resistant lines and H-2 recombinants, were studied. The strains could be classified as high responders, low responders, or nonresponders to a particular antigen as judged by the magnitude of the T-lymphocyte proliferative response. In every case but one this classification corresponded to the responder status given the strain based on its ability to mount an in vivo antibody response to the same antigen. For two of the antigens, poly-(Tyr,Glu)-poly-D,L-Ala--poly-Lys and TEPC-15, the immune response genes controlling the T-lymphocyte proliferative response were mapped to the K region or I-A subregion of the major histocompatibility complex, as had previously been shown for the control of the antibody responses to these antigens. This tight linkage of the two phenotypic responses very strongly suggests that the same immune response gene controls the expression of both the proliferative and antibody responses. Since there is essentially no contribution from B lymphocytes in the T-lymphocyte proliferation assay, it seems reasonable to conclude that none of the seven immune response genes studied are expressed solely in B lymphocytes.
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